Could your own hair follicles cure baldness? new trial begins

NCT ID NCT07107841

Recruiting now Disease control Sponsor: Acorn Biolabs Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a treatment called autologous hair follicle secretome (aHFS) for androgenic alopecia (common baldness). The treatment is made by taking hair follicles from the person, growing them in a lab, and collecting the substances they release. These are then injected into the scalp over a year. The trial involves 60 people and compares the active treatment to a placebo. The goal is to see if it safely increases hair density and thickness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: autologous hair follicle secretome (aHFS)
What this could lead to: If it works, this could offer a new, natural-looking treatment for hair loss using your own cells.
What could go wrong: This is an early, small trial (60 people) with no phase. The treatment is experimental, and results may not apply to everyone. Side effects are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALOPECIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alopecia androgenetic alopecia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALOPECIA ANDROGENIC ALOPECIA BALDNESS

Contacts and locations

Locations

Ziering Medical
RECRUITING

West Hollywood, California, 90069, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.